PharmaPoint: Chronic Heart Failure - United Kingdom Drug Forecast and Market Analysis to 2022 - New Market Research Report
GlobalData has released its new Country report, "PharmaPoint: Chronic Heart Failure - United Kingdom Drug Forecast and Market Analysis to 2022". The chronic heart failure (CHF) market is a mature market that has been slowly overtaken by generic drugs, and more branded products are expected to lose market exclusivity during the next few years. GlobalData predicts that the major global barriers that will play a crucial role in narrowing the global growth of the CHF market over the forecast period...
View full press release